SGLT2 inhibitors and risk of cancer in type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials
Crossref DOI link: https://doi.org/10.1007/s00125-017-4370-8
Published Online: 2017-07-19
Published Print: 2017-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tang, Huilin
Dai, Qi
Shi, Weilong
Zhai, Suodi
Song, Yiqing
Han, Jiali
Funding for this research was provided by:
Indiana University Health–Indiana University School of Medicine Strategic Research Initiative
License valid from 2017-07-19